Covaxin 50% effective against delta variant, shows study - Here's all you need to know

Two doses of Covaxin have shown 50 per cent effectiveness against symptomatic disease, according to the first real-world assessment of India's indigenous COVID-19 vaccine.

Related Keywords

Delhi ,India ,New Delhi ,Pune ,Maharashtra ,Bharat ,Manish Soneja ,Parul Kodan ,National Institute Of Virology ,World Health Organization ,Indian Council Of Medical Research ,India Institute Of Medical Sciences ,Hyderabad Based Bharat Biotech ,National Institute ,Indian Council ,Medical Research ,All India Institute ,Medical Sciences ,Additional Professor ,Assistant Professor ,Covid 19 ,Covaxin ,